التفاصيل البيبلوغرافية
| العنوان: |
Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. |
| المؤلفون: |
Walker, Zuzana, Costa, Durval C., Janssen, Anthony G., Walker, Rodney W. H., Livingstone, Gillian, Katona, Cornelius L. E. |
| المصدر: |
European Journal of Nuclear Medicine; 1997, Vol. 24 Issue 6, p609, 6p |
| مصطلحات موضوعية: |
LEWY body dementia, DOPAMINE receptors, IODINE, POSITRON emission tomography |
| مستخلص: |
Dementia with Lewy bodies (DLB) can at present only be diagnosed with certainty by neuropathological examination. Diagnosis during life remains at best probable, based on the presence of symptoms known from autopsy studies to be frequently associated with DLB. The greatest practical clinical problem lies in distinguishing DLB and Alzheimer's disease (AD). In DLB there is a considerable degeneration of nigral neurones with depletion of striatal dopamine. In contrast, AD is not associated with significant changes in dopamine metabolism. Iodine-123 iodobenzamide singlephoton emission tomography (IBZM-SPET) measures post-synaptic dopamine D[sub 2] neuroreceptor availability in the corpus striatum, but is nevertheless a method for assessing the integrity of the nigrostriatal dopaminergic pathway. Sixteen clinically diagnosed DLB patients, 15 normal controls and 13 AD patients underwent IBZMSPET. All subjects were scanned 1.5-2 h after intravenous injection of 185 MBq of [sup 123]I-IBZM. Circular regions of interest were employed to calculate radioactivity ratios in each hemisphere as follows: caudate nucleus/frontal cortex, putamen/frontal cortex and caudate nucleus/putamen. The DLB patients had significantly lower left caudate/putamen ratios (95% confidence intervals: DLB 0.893-0.965, AD 0.972-1.175, controls 1.031-1.168) than either controls or AD patients, and significantly lower right caudate/putamen ratios (95% confidence intervals: DLB 0.926-1.019, AD 0.954-1.103, controls 1.027-1.144) than controls. Our data suggest that patients with DLB diagnosed by clinical criteria have changes in striatal post-synaptic D[sub 2] receptors. This may be of value in distinguishing DLB from AD during life. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Nuclear Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
